A 64-year-old woman with well-controlled hypertension and no diabetes presents without fractures or glucocorticoid use. According to the 2023 Osteoporosis Canada guideline, which woman should be considered for pharmacologic osteoporosis therapy?AA 50-year-old woman with normal BMD and no risk factorsBA 68-year-old woman with prior hip fractureCA 45-year-old woman with BMI 32 kg/m² and no other risk factorsDA 60-year-old woman with T-score -1.0 at the femoral neck and FRAX risk 5%ENo women should receive therapy unless they have two or more fracturesCheck my answer